Development of glucosamine functionaliZed micelles as a potential drug delivery system for targeting to brain

References

• Safavy A, Raisch KP, Mantena S, et al. Design and development of water-soluble curcumin conjugates as potential anticancer agents. J Med Chem. 2007;50:6284–6288.
   PubMed Web of Science ®Google Scholar
• Gou M, Men K, Shi H, et al. Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo. Nanoscale. 2011;3:1558–1567.
   PubMed Web of Science ®Google Scholar
• Abouzeid AH, Patel NR, Torchilin VP. Polyethylene glycol-phosphatidylethanolamine (PEG-PE)/vitamin e micelles for co-delivery of paclitaxel and curcumin to overcome multi-drug resistance in ovarian cancer. Int J Pharm. 2014;464:178–184.
   PubMed Web of Science ®Google Scholar
• Sood S, Jain K, Gowthamarajan K. Optimization of curcumin nanoemulsion for intranasal delivery using design of experiment and its toxicity assessment. Colloids Surf B Biointerfaces. 2014;113:330–337.
   PubMed Web of Science ®Google Scholar
• Song L, Shen Y, Hou J, et al. Polymeric micelles for parenteral delivery of curcumin: preparation, characterization and in vitro evaluation. Colloids Surf A Physicochem Eng Asp. 2011;390:25–32.
   Web of Science ®Google Scholar
• Zhao L, Du J, Duan Y, et al. Curcumin loaded mixed micelles composed of Pluronic P123 and F68: preparation, optimization and in vitro characterization. Colloids Surf B Biointerfaces. 2012;97:101–108.
   PubMed Web of Science ®Google Scholar
• Li M, Zhang Z, Hill DL, et al. Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway. Cancer Res. 2007;67:1988–1996.
   PubMed Web of Science ®Google Scholar
• Madane RG, Mahajan HS. Curcumin-loaded nanostructured lipid carriers (NLCs) for nasal administration: design, characterization, and in vivo study. Drug Deliv. 2016;23:1326–1334.
   PubMed Web of Science ®Google Scholar
• Saenz del Burgo L, Hernández RM, Orive G, et al. Nanotherapeutic approaches for brain cancer management. Nanomed Nanotechnol Biol Med. 2014;10:905–919.
   PubMed Web of Science ®Google Scholar
• Alam MI, Beg S, Samad A, et al. Strategy for effective brain drug delivery. Eur J Pharm Sci. 2010;40:385–403.
   PubMed Web of Science ®Google Scholar
• Kulkarni SA, Feng S. Effects of surface modification on delivery efficiency of biodegradable nanoparticles across the blood–brain barrier. Nanomed. 2011;6:377–394.
   PubMed Web of Science ®Google Scholar
• Sonali PA, Singh RP, Rajesh CV, et al. Transferrin receptor-targeted vitamin E TPGS micelles for brain cancer therapy: preparation, characterization and brain distribution in rats. Drug Deliv. 2016;23:1788–1798.
   PubMed Web of Science ®Google Scholar
• Gan CW, Feng SS. Transferrin-conjugated nanoparticles of Poly(lactide)-d-α-Tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier. Biomaterials. 2010;31:7748–7757.
   PubMed Web of Science ®Google Scholar
• Wohlfart S, Gelperina S, Kreuter J. Transport of drugs across the blood-brain barrier by nanoparticles. J Control Release. 2012;161:264–273.
   PubMed Web of Science ®Google Scholar
• Wang K, Nune KC, Misra RDK. Acta biomaterialia the functional response of alginate-gelatin-nanocrystalline cellulose injectable hydrogels toward delivery of cells and bioactive molecules. Acta Biomater. 2016;36:143–151.
   PubMed Web of Science ®Google Scholar
• Wang K, Buschle-Diller G, Misra RD. Chitosan-based injectable hydrogels for biomedical applications. Mater Technol. 2016;7857. DOI:10.1179/17535557B15Y.000000008
   Google Scholar
• Wang K, Lin S, Nune KC, et al. Chitosan-gelatin-based microgel for sustained drug delivery. J Biomater Sci Polym Ed. 2016;5063:0–13.
   Google Scholar
• Muthu MS, Singh S. Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders. Nanomedicine. 2009;4:105–118.
   PubMed Web of Science ®Google Scholar
• Kim S, Shi Y, Kim JY, et al. Overcoming the barriers in micellar drug delivery: loading efficiency, in vivo stability, and micelle–cell interaction. Expert Opin Drug Deliv. 2010;7:49–62.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Tan S, Feng SS. Vitamin E TPGS as a molecular biomaterial for drug delivery. Biomaterials. 2012;33:4889–4906.
   PubMed Web of Science ®Google Scholar
• Vijayakumar MR, Muthu MS, Singh S. Copolymers of poly(lactic acid) and d -α-tocopheryl polyethylene glycol 1000 succinate-based nanomedicines: versatile multifunctional platforms for cancer diagnosis and therapy. Expert Opin Drug Deliv. 2013;10:529–543.
   PubMed Web of Science ®Google Scholar
• Kutty RV, Chia SL, Setyawati MI, et al. In vivo and ex vivo proofs of concept that cetuximab conjugated vitamin E TPGS micelles increases efficacy of delivered docetaxel against triple negative breast cancer. Biomaterials. 2015;63:58–69.
   PubMed Web of Science ®Google Scholar
• Muthu MS, Kulkarni SA, Xiong J, et al. Vitamin e TPGS coated liposomes enhanced cellular uptake and cytotoxicity of docetaxel in brain cancer cells. Int J Pharm. 2011;421:332–340.
   PubMed Web of Science ®Google Scholar
• Feng SS. New-concept chemotherapy by nanoparticles of biodegradable polymers: where are we now? Nanomedicine. 2006;1:297–309.
   PubMed Web of Science ®Google Scholar
• Si-shen Zhao Lingyun F. Enhanced oral bioavailability of paclitaxel formulated in vitamin E-TPGS nanoparticles of biodegradable polymers: in vitro and in vivo studies. J Pharm Sci. 2010;99:3552–3560.
   PubMed Web of Science ®Google Scholar
• Kim GEW, Ivan M, Chiche J, et al. Tumour hypoxia induces a metabolic shift causing acidosis : a common feature in cancer. J Cell Mol Med. 2010;14:771–794.
   PubMed Web of Science ®Google Scholar
• Yamamoto T. Received M.sy 31, 1990. Biochem Biophys Res Commun. 1990;170:223–230.
   PubMed Web of Science ®Google Scholar
• Smita PRV, Pawara K, Badhwarb AJ, et al. Design, synthesis and evaluation of N-acetyl glucosamine (NAG)–PEG–doxorubicin targeted conjugates for anticancer delivery Smita. Int J Pharm. 2012;436:183–193.
   PubMedGoogle Scholar
• Pawar S, Vavia P. Glucosamine anchored cancer targeted nano-vesicular drug delivery system of doxorubicin. J Drug Target. 2016;24:68–79.
   PubMed Web of Science ®Google Scholar
• Muthu MS, Kutty RV, Luo Z, et al. Theranostic vitamin E TPGS micelles of transferrin conjugation for targeted co-delivery of docetaxel and ultra bright gold nanoclusters. Biomaterials. 2015;39:234–248.
   PubMed Web of Science ®Google Scholar
• Raju A, Muthu MS, Feng -S-S. Trastuzumab-conjugated vitamin E TPGS liposomes for sustained and targeted delivery of docetaxel. Expert Opin Drug Deliv. 2013;10:747–760.
   PubMed Web of Science ®Google Scholar
• Wei Z, Hao J, Yuan S, et al. Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization. Int J Pharm. 2009;376:176–185.
   PubMed Web of Science ®Google Scholar
• Muthu MS, Avinash Kulkarni S, Liu Y, et al. Development of docetaxel-loaded vitamin e TPGS micelles: formulation optimization, effects on brain cancer cells and biodistribution in rats. Nanomedicine. 2012;7:353–364.
   PubMed Web of Science ®Google Scholar
• Muthu MS, Sahu AK, Sonali AA, et al. Solubilized delivery of paliperidone palmitate by d- alpha-tocopheryl polyethylene glycol 1000 succinate micelles for improved short-term psychotic management. Drug Deliv. 2016;23:230–237.
   PubMed Web of Science ®Google Scholar
• Khodabandehloo H, Zahednasab H, Ashrafi Hafez A. Nanocarriers usage for drug delivery in cancer therapy. Iran J Cancer Prev. In Press. 2016. DOI:10.17795/ijcp-3966
   PubMedGoogle Scholar